The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm
Open accessAbstract
For the past decade, cardiac safety screening to evaluate the propensity of drugs to produce QT interval prolongation and Torsades de Pointes (TdP) arrhythmia has been conducted according to ICH S7B and ICH E14 guidelines. Central to the existing approach are hERG channel assays and in vivo QT measurements. Although effective, the present paradigm carries a risk of unnecessary compound attrition and high cost, especially when considering costly thorough QT (TQT) studies conducted later in drug development. The C: omprehensive I: n Vitro P: roarrhythmia A: ssay (CiPA) initiative is a public-private collaboration with the aim of updating the existing cardiac safety testing paradigm to better evaluate arrhythmia risk and remove the need for TQT studies. It is hoped that CiPA will produce a standardized ion channel assay approach, incorporating defined tests against major cardiac ion channels, the results of which then inform evaluation of proarrhythmic actions in silico, using human ventricular action potential reconstructions. Results are then to be confirmed using human (stem cell-derived) cardiomyocytes. This perspective article reviews the rationale, progress of, and challenges for the CiPA initiative, if this new paradigm is to replace existing practice and, in time, lead to improved and widely accepted cardiac safety testing guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
O'Hara, T., Virág, L., Varró, A., & Rudy, Y. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002061 · Cited by 1,196 · cited 1×
“edu); all constants (extracellular ionic concentrations, cell geometry, ionic conductance) and all the initial conditions for state variable and scaling factors have been determined; and, finally, it is fully validated with ionic data described for a human ventricular AP model.(40) The ISWG is focused on evaluating an…”
MethodDrug induced QT prolongation and torsades de pointes
Yap, Y. G., & Camm, A. J. (2003) · Heart · doi:10.1136/heart.89.11.1363 · Cited by 958
Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
Yang, X., Pabon, L., & Murry, C. E. (2014) · Circulation Research · doi:10.1161/circresaha.114.300558 · Cited by 939
Ma, J., Guo, L., Fiene, S. J., Anson, B. D., Thomson, J. A., Kamp, T. J., Kolaja, K. L., Swanson, B. J., & January, C. T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00694.2011 · Cited by 770
Sager, P. T., Gintant, G., Turner, J. R., Pettit, S., & Stockbridge, N. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.11.004 · Cited by 540
Self-citationThe impact of drug-induced QT interval prolongation on drug discovery and development
Fermini, B., & Fossa, A. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1108 · Cited by 492
Self-citationA common polymorphism associated with antibiotic-induced cardiac arrhythmia
Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L., & Goldstein, S. A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180223197 · Cited by 479
A minK–HERG complex regulates the cardiac potassium current IKr
McDonald, T. V., Yu, Z., Ming, Z., Palma, E., Meyers, M. B., Wang, K.-W., Goldstein, S. A. N., & Fishman, G. I. (1997) · Nature · doi:10.1038/40882 · Cited by 387
Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels
Zhang, S., Zhou, Z., Gong, Q., Makielski, J. C., & January, C. T. (1999) · Circulation Research · doi:10.1161/01.res.84.9.989 · Cited by 366
Concise Review: Maturation Phases of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Robertson, C., Tran, D. D., & George, S. C. (2013) · Stem Cells · doi:10.1002/stem.1331 · Cited by 354
MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
Kramer, J., Obejero-Paz, C. A., Myatt, G., Kuryshev, Y. A., Bruening-Wright, A., Verducci, J. S., & Brown, A. M. (2013) · Scientific Reports · doi:10.1038/srep02100 · Cited by 347
Self-citationMirams, G. R., Cui, Y., Sher, A., Fink, M., Cooper, J., Heath, B. M., McMahon, N. C., Gavaghan, D. J., & Noble, D. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr044 · Cited by 326
The hERG potassium channel and hERG screening for drug-induced torsades de pointes
Hancox, J. C., McPate, M. J., El Harchi, A., & Zhang, Y. H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.009 · Cited by 299
Self-citationKirsch, G. E., Trepakova, E. S., Brimecombe, J. C., Sidach, S. S., Erickson, H. D., Kochan, M. C., Shyjka, L. M., Lacerda, A. E., & Brown, A. M. (2004) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2004.06.003 · Cited by 241
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
Trinkley, K. E., Lee Page, R., Lien, H., Yamanouye, K., & Tisdale, J. E. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.840568 · Cited by 228
Gintant, G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.008 · Cited by 222
Self-citationRefining detection of drug-induced proarrhythmia: QT interval and TRIaD
Shah, R. R., & Hondeghem, L. M. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.03.023 · Cited by 205
Cardiac IKr Channels Minimally Comprise hERG 1a and 1b Subunits
Jones, E. M. C., Roti, E. C. R., Wang, J., Delfosse, S. A., & Robertson, G. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408344200 · Cited by 195
Weerapura, M., Nattel, S., Chartier, D., Caballero, R., & Hébert, T. E. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013296 · Cited by 193
Rao, C., Prodromakis, T., Kolker, L., Chaudhry, U. A. R., Trantidou, T., Sridhar, A., Weekes, C., Camelliti, P., Harding, S. E., Darzi, A., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.055 · Cited by 176
Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias
Yang, T., Snyders, D., & Roden, D. M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200111000-00010 · Cited by 171
Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Lee, Y.-K., Ng, K., Lai, W., Chan, Y.-C., Lau, Y., Lian, Q., Tse, H., & Siu, C. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9273-3 · Cited by 163
Pollard, C., Abi Gerges, N., Bridgland‐Taylor, M., Easter, A., Hammond, T., & Valentin, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00207.x · Cited by 160
Self-citationBridgland-Taylor, M., Hargreaves, A. C., Easter, A., Orme, A. T., Henthorn, D., Ding, M., Davis, A. M., Small, B. G., Heapy, C. G., Abi‐Gerges, N., et al. (2006) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2006.02.003 · Cited by 149
Self-citationJonsson, M. K. B., Vos, M. A., Mirams, G. R., Duker, G., Sartipy, P., de Boer, T. P., & van Veen, T. A. B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.002 · Cited by 138
Hanson, L. A., Bass, A. S., Gintant, G. A., Mittelstadt, S. W., Rampe, D., & Thomas, K. (2006) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2006.05.001 · Cited by 124
Self-citationHarmer, A. R., Abi‐Gerges, N., Easter, A., Woods, A., Lawrence, C., Small, B. G., Valentin, J., & Pollard, C. E. (2007) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2007.09.002 · Cited by 119
Self-citationBett, G. C. L., Kaplan, A. D., Lis, A., Cimato, T. R., Tzanakakis, E. S., Zhou, Q., Morales, M. J., & Rasmusson, R. L. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.09.061 · Cited by 118
Early identification of hERG liability in drug discovery programs by automated patch clamp
Danker, T., & Moeller, C. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00203 · Cited by 113
Scott, C. W., Zhang, X., Abi‐Gerges, N., Lamore, S. D., Abassi, Y. A., & Peters, M. F. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu186 · Cited by 106
Self-citationMilnes, J. T., Witchel, H. J., Leaney, J. L., Leishman, D. J., & Hancox, J. C. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.02.007 · Cited by 101
Self-citationCellular Basis for the Repolarization Waves of the ECG
Antzelevitch, C. N. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1380.021 · Cited by 98
hERG 1b is critical for human cardiac repolarization
Jones, D. K., Liu, F., Vaidyanathan, R., Eckhardt, L. L., Trudeau, M. C., & Robertson, G. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414945111 · Cited by 96
Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety
Gintant, G. A., Su, Z. G., Martin, R. L., & Cox, B. F. (2006) · Toxicologic Pathology · doi:10.1080/01926230500431376 · Cited by 91
Self-citationCardiotoxicity of new antihistamines and cisapride
Paakkari, I. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00510-0 · Cited by 90
Gintant, G. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.010 · Cited by 81
Self-citationHigh-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment
Veroli, G. Y. D., Davies, M. R., Zhang, H., Abi‐Gerges, N., & Boyett, M. R. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00511.2012 · Cited by 76
Self-citationMolecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy
Abriel, H., Gavillet, B., Biollaz, J., & Stoller, R. (2004) · Swiss Medical Weekly · doi:10.4414/smw.2004.10532 · Cited by 74
Darpö, B., Garnett, C. E., Benson, C., Keirns, J. J., Leishman, D. J., Malík, M., Mehrotra, N., Prasad, K., Riley, S., Rodríguez, I., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.06.003 · Cited by 63
Friedrichs, G. S., Patmore, L., & Bass, A. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.05.001 · Cited by 63
Du, C., Harchi, A. E., Zhang, H., & Hancox, J. C. (2013) · Physiological Reports · doi:10.1002/phy2.175 · Cited by 41
Self-citationKang, J., Chen, X., Ji, J., Lei, Q., & Rampe, D. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192609 · Cited by 37
Self-citationQu, Y., Gao, B., Fang, M., & Vargas, H. M. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.03.001 · Cited by 36
Cited by
Computational models in cardiology
Niederer, S. A., Lumens, J., & Trayanova, N. A. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0104-y · Cited by 434
Human Engineered Heart Tissue: Analysis of Contractile Force
Mannhardt, I., Breckwoldt, K., Letuffe-Brenière, D., Schaaf, S., Schulz, H., Neuber, C., Benzin, A., Werner, T., Eder, A., Schulze, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.011 · Cited by 398
Blinova, K., Dang, Q., Millard, D., Smith, G., Pierson, J., Guo, L., Brock, M., Lu, H. R., Kraushaar, U., Zeng, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.079 · Cited by 373
Self-citationhERG toxicity assessment: Useful guidelines for drug design
Garrido, A., Lepailleur, A., Mignani, S. M., Dallemagne, P., & Rochais, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112290 · Cited by 344
Crumb, W. J., Vicente, J., Johannesen, L., & Strauss, D. G. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.03.009 · Cited by 288
Self-citation
Metadata
- Authors
- Fermini, B., Hancox, J. C., Abi-Gerges, N., Bridgland-Taylor, M., Chaudhary, K. W., Colatsky, T., Correll, K., Crumb, W., Damiano, B., Erdemli, G., Gintant, G., Imredy, J., Koerner, J., Kramer, J., Levesque, P., Li, Z., Lindqvist, A., Obejero-Paz, C. A., Rampe, D., Sawada, K., Strauss, D. G., & Vandenberg, J. I.
- Venue
- SLAS Discovery
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 21
- Issue
- 1
- Pages
- 1-11
- ISSN
- 2472-5552 (ISSN-L)
- OpenAlex
- W878990122
- Cited by
- 302
- References
- 45
- FWCI
- 26.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.